Literature DB >> 15099523

Vpu-mediated degradation of CD4 reconstituted in yeast reveals mechanistic differences to cellular ER-associated protein degradation.

Birgit Meusser1, Thomas Sommer.   

Abstract

In HIV infected cells, the plasma membrane protein CD4 is removed from the secretory pathway by proteasomal digestion. This crucial step of viral infection occurs at the endoplasmic reticulum and is triggered by the HIV encoded protein Vpu. Here we show that this process can be recapitulated in baker's yeast. The analysis in the yeast system revealed that Vpu-induced breakdown of CD4 occurs independently of the cellular ER-associated protein degradation system. Moreover, our system allows direct comparison between Vpu-mediated turnover and cellular ER-associated protein degradation of CD4. This analysis suggests fundamental mechanistic differences between both pathways: Vpu-induced turnover strictly relies on ubiquitination of CD4 at cytosolic lysine residues prior to export of the substrate from the membrane. In contrast, the cellular ER-associated protein degradation pathway can transport ER-lumenal parts of CD4 into the cytoplasm before ubiquitination and extraction of the membrane anchor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099523     DOI: 10.1016/s1097-2765(04)00212-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  27 in total

1.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  The Hrd1p ligase complex forms a linchpin between ER-lumenal substrate selection and Cdc48p recruitment.

Authors:  Robert Gauss; Thomas Sommer; Ernst Jarosch
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

3.  Dissecting the ER-associated degradation of a misfolded polytopic membrane protein.

Authors:  Kunio Nakatsukasa; Gregory Huyer; Susan Michaelis; Jeffrey L Brodsky
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

Review 4.  The Vpu protein: new concepts in virus release and CD4 down-modulation.

Authors:  Autumn Ruiz; John C Guatelli; Edward B Stephens
Journal:  Curr HIV Res       Date:  2010-04       Impact factor: 1.581

5.  Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain.

Authors:  Jean K Gustin; Janet L Douglas; Ying Bai; Ashlee V Moses
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

Review 6.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

7.  Analysis of COPII Vesicles Indicates a Role for the Emp47-Ssp120 Complex in Transport of Cell Surface Glycoproteins.

Authors:  Neil G Margulis; Joshua D Wilson; Christine M Bentivoglio; Nripesh Dhungel; Aaron D Gitler; Charles Barlowe
Journal:  Traffic       Date:  2016-01-10       Impact factor: 6.215

8.  Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps.

Authors:  Javier G Magadán; F Javier Pérez-Victoria; Rachid Sougrat; Yihong Ye; Klaus Strebel; Juan S Bonifacino
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

9.  Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.

Authors:  Cristian De Candia; Constanza Espada; Gabriel Duette; Yanina Ghiglione; Gabriela Turk; Horacio Salomón; Mauricio Carobene
Journal:  Virol J       Date:  2010-10-04       Impact factor: 4.099

10.  HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

Authors:  Bastien Mangeat; Gustavo Gers-Huber; Martin Lehmann; Madeleine Zufferey; Jeremy Luban; Vincent Piguet
Journal:  PLoS Pathog       Date:  2009-09-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.